Efficacy assessment of CellSlide in liquid-based gynecologic cytology.

OBJECTIVE To evaluate the efficacy of CellSlidetrade mark (CS) method in liquid-based gynecologic cytology. METHODS We compared 1221 specimens prepared by both CS and conventional techniques to evaluate specimen adequacy and cytologic diagnoses. Sensitivity and specificity of these techniques were analyzed in 54 cases using the available histological data. RESULTS Quality limiting factors, such as obscuring inflammation or blood, were markedly reduced in CS (0.2%) compared to the conventional smear (4.9%). There was a complete agreement in the Bethesda 2001 diagnosis between these methods in 1132 cases (92.7%) out of 1221. 16.7% more ASC cases and 37.5% more low-grade squamous intraepithelial lesions (LSIL) and 21.4% more high-grade SIL (HSIL) were detected on the CS slides than on the conventional smears. Sensitivity rates, relative to histological data, were 91.4% (CS) and 74.3% (conventional) and specificity rates were same (89.5%) for ASC and more severe lesions. Infectious organisms (Trichomonas and Candida, etc.) were readily identifiable in both methods. CONCLUSIONS CS preparation is more sensitive and equally specific in detecting epithelial abnormalities when compared to the conventional smear. In addition, it has a lower incidence of unsatisfactory results with hypocellularity or >75% obscuration of cells.

[1]  J Linder,et al.  Recent advances in thin‐layer cytology. , 1998, Diagnostic cytopathology.

[2]  J Monsonego,et al.  Liquid-based cytology for primary cervical cancer screening: a multi-centre study , 2001, British Journal of Cancer.

[3]  Attila Lorincz,et al.  Cervical biopsy‐based comparison of a new liquid‐based thin‐layer preparation with conventional Pap smears , 2004, Diagnostic cytopathology.

[4]  M. Melamed,et al.  SpinThin, a simple, inexpensive technique for preparation of thin‐layer cervical cytology from liquid‐based specimens , 2000, Cancer.

[5]  Mark Sherman,et al.  The 2001 Bethesda System: terminology for reporting results of cervical cytology. , 2002, JAMA.

[6]  A. Cheung,et al.  Liquid‐based cytology and conventional cervical smears , 2003 .

[7]  A. Hanselaar,et al.  Liquid‐based cervical cytology , 2003, Cancer.

[8]  M. A. Sass Use of a Liquid-Based, Thin-Layer Pap Test in a Community Hospital , 2004, Acta Cytologica.

[9]  R. Ashfaq,et al.  Performance of liquid-based, thin-layer cervical cytology: correlation with reference diagnoses and human papillomavirus testing. , 1998, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[10]  T. Colgan Programmatic assessments of the clinical effectiveness of gynecologic liquid‐based cytology , 2003, Cancer.

[11]  Jacalyn L. Papillo,et al.  Evaluation of the ThinPrep Pap Test in Clinical Practice , 1998, Acta Cytologica.

[12]  L. Mango,et al.  Cervical specimens collected in liquid buffer are suitable for both cytologic screening and ancillary human papillomavirus testing , 1997, Cancer.

[13]  D. Sherer,et al.  Performance of ThinPrep liquid-based cervical cytology in comparison with conventionally prepared Papanicolaou smears: a quantitative survey. , 2003, Gynecologic oncology.

[14]  Experience with a Thin-Layer, Liquid-Based Cervical Cytologic Screening Method , 2003, Acta Cytologica.